These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37778994)
1. Catalpol Inhibits Autophagy to Ameliorate Doxorubicin-Induced Cardiotoxicity via the AKT-mTOR Pathway. Liu B; Xie H; Du X; Zhou Y; Huang J Int Heart J; 2023; 64(5):910-917. PubMed ID: 37778994 [TBL] [Abstract][Full Text] [Related]
2. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling. Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329 [TBL] [Abstract][Full Text] [Related]
3. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity. Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084 [TBL] [Abstract][Full Text] [Related]
4. RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway. Jiao Y; Li Y; Zhang J; Zhang S; Zha Y; Wang J Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204799 [TBL] [Abstract][Full Text] [Related]
5. Sevoflurane ameliorates doxorubicin-induced myocardial injury by affecting the phosphorylation states of proteins in PI3K/Akt/mTOR signaling pathway. Wu Y; Wang J; Yu X; Li D; Han X; Fan L Cardiol J; 2017; 24(4):409-418. PubMed ID: 28198521 [TBL] [Abstract][Full Text] [Related]
7. Protective role of cezanne in doxorubicin-induced cardiotoxicity by inhibiting autophagy, apoptosis and oxidative stress. Zhang J; Zha Y; Jiao Y; Li Y; Zhang S Toxicology; 2023 Feb; 485():153426. PubMed ID: 36639017 [TBL] [Abstract][Full Text] [Related]
8. Sophocarpine alleviates doxorubicin-induced heart injury by suppressing oxidative stress and apoptosis. Zhang HJ; Fu Y; Zhang H; Lai ZQ; Dong YF Sci Rep; 2024 Jan; 14(1):428. PubMed ID: 38172265 [TBL] [Abstract][Full Text] [Related]
9. SIRT4 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the AKT/mTOR/Autophagy Pathway. He L; Wang J; Yang Y; Zou P; Xia Z; Li J Toxicology; 2022 Mar; 469():153119. PubMed ID: 35134463 [TBL] [Abstract][Full Text] [Related]
10. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress. Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254 [TBL] [Abstract][Full Text] [Related]
11. Protective Effects of Li J; Cheng Y; Li R; Wu X; Zheng C; Shiu PH; Chan JC; Rangsinth P; Liu C; Leung SW; Lee SM; Zhang C; Fu C; Zhang J; Cheung TM; Leung GP Oxid Med Cell Longev; 2022; 2022():9266178. PubMed ID: 35693699 [TBL] [Abstract][Full Text] [Related]
12. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway. Zhang J; Jiang H; Liu DH; Wang GN Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917 [TBL] [Abstract][Full Text] [Related]
13. Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy. Wu S; Chang G; Gao L; Jiang D; Wang L; Li G; Luo X; Qin S; Guo X; Zhang D J Mol Med (Berl); 2018 Aug; 96(8):791-806. PubMed ID: 29955901 [TBL] [Abstract][Full Text] [Related]
14. Qishen granule attenuates doxorubicin-induced cardiotoxicity by protecting mitochondrial function and reducing oxidative stress through regulation of Sirtuin3. Zhang J; Li W; Xue S; Gao P; Wang H; Chen H; Hong Y; Sun Q; Lu L; Wang Y; Wang Q J Ethnopharmacol; 2024 Jan; 319(Pt 1):117134. PubMed ID: 37714227 [TBL] [Abstract][Full Text] [Related]
15. Qishen Huanwu capsule reduces pirarubicin-induced cardiotoxicity in rats by activating the PI3K/Akt/mTOR pathway. Wang F; Wang L; Jiao Y; Wang Z Ann Palliat Med; 2020 Sep; 9(5):3453-3461. PubMed ID: 33065796 [TBL] [Abstract][Full Text] [Related]
16. β-LAPachone ameliorates doxorubicin-induced cardiotoxicity via regulating autophagy and Nrf2 signalling pathways in mice. Nazari Soltan Ahmad S; Sanajou D; Kalantary-Charvadeh A; Hosseini V; Roshangar L; Khojastehfard M; Haiaty S; Mesgari-Abbasi M Basic Clin Pharmacol Toxicol; 2020 Apr; 126(4):364-373. PubMed ID: 31630478 [TBL] [Abstract][Full Text] [Related]
17. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of dimethyl itaconate in mice acute cardiotoxicity induced by doxorubicin. Shan Q; Li X; Zheng M; Lin X; Lu G; Su D; Lu X Biochem Biophys Res Commun; 2019 Sep; 517(3):538-544. PubMed ID: 31376936 [TBL] [Abstract][Full Text] [Related]
19. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK. Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112 [TBL] [Abstract][Full Text] [Related]
20. Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy. Sun A; Cheng Y; Zhang Y; Zhang Q; Wang S; Tian S; Zou Y; Hu K; Ren J; Ge J J Mol Cell Cardiol; 2014 Jun; 71():92-104. PubMed ID: 24434637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]